Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
298
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis

Amer M. ZeidanDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA; Correspondence[email protected]
,
Weiwei ZhuCancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA; ;Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, CT, USA;
,
Maximilian StahlDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA; ;Department of Medicine, Section of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA;
,
Rong WangCancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA; ;Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, CT, USA;
,
Scott F. HuntingtonDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA;
,
Smith GiriDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA;
,
Nikolai A. PodoltsevDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA;
,
Steven D. GoreDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA; ;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA;
,
Xiaomei MaCancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA; ;Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, CT, USA;
&
Amy J. DavidoffCancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA; ;Department of Health Policy and Management, School of Public Health, Yale University, New Haven, CT, USA
 show all
Pages 3181-3187 | Received 24 Mar 2019, Accepted 13 May 2019, Published online: 07 Jun 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Hans Tilman Steinmetz, J. Toczek-Thiel, J. Lipke, R. Liersch, A. Sauer, H. Tesch, J. Heßling, U. Totzke & S. Schmitz. (2023) Time to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of survival. Leukemia & Lymphoma 64:8, pages 1476-1479.
Read now
Suleyman Yasin Goksu, Muhammet Ozer, Busra B. Goksu, Rong Wang, Jude Khatib, Prapti A. Patel, Madhuri Vusirikala, Suzanne Cole, Ahmet Seyhanli, Robert H. Collins, Stephen Chung, Amer M. Zeidan & Yazan F. Madanat. (2022) The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis. Leukemia & Lymphoma 63:7, pages 1651-1659.
Read now
Russell Lewis, Jan Philipp Bewersdorf & Amer M Zeidan. (2021) Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options. Cancer Management and Research 13, pages 645-657.
Read now
M. Cruijsen, W.J.F.M van der Velden, A.F.J. de Haan, S. K. Klein, M. Hoogendoorn, Y. Tromp, B. de Valk, B. van Rees, F. de Boer, E. van der Spek, J. Pruijt, L.F. Verdonck, E. Vellenga, N. Blijlevens, A. A. van de Loosdrecht & G. Huls. (2020) Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Leukemia & Lymphoma 61:11, pages 2752-2755.
Read now

Articles from other publishers (3)

Almuth Maria Anni Merz & Uwe Platzbecker. (2023) Beyond the horizon: Emerging therapeutic approaches in Myelodysplastic Neoplasms. Experimental Hematology.
Crossref
Rafael Bejar. (2022) Can Lower-Risk MDS Achieve High Reward with Hypomethylating Agent Therapy?. NEJM Evidence 1:10.
Crossref
Amer M. ZeidanRong Wang, Xiaoyi Wang, Rory M. Shallis, Nikolai A. Podoltsev, Jan P. BewersdorfScott F. Huntington, Natalia NeparidzeSmith GiriSteven D. GoreAmy J. Davidoff & Xiaomei Ma. (2020) Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States. Blood Advances 4:10, pages 2192-2201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.